{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:27:16Z","timestamp":1793330836564,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["ARS01_01220"],"award-info":[{"award-number":["ARS01_01220"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e0 del Salento"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>\n                        <jats:italic>Abstract<\/jats:italic>\n                     <\/jats:title><jats:p><jats:italic>Winnie<\/jats:italic>, a mouse carrying a missense mutation in the <jats:italic>MUC2<\/jats:italic> mucin gene, is a valuable model for inflammatory bowel disease (IBD) with signs and symptoms that have multiple similarities with those observed in patients with ulcerative colitis. MUC2 mucin is present in <jats:italic>Winnie<\/jats:italic>, but is not firmly compacted in a tight inner layer. Indeed, these mice develop\u00a0chronic intestinal inflammation due to the primary epithelial defect with signs of mucosal damage, including thickening of muscle and mucosal layers, goblet cell loss, increased intestinal permeability, enhanced susceptibility to luminal inflammation-inducing toxins, and alteration of innervation in the distal colon. In this study, we show that the intestinal environment of the <jats:italic>Winnie<\/jats:italic> mouse, genetically determined by <jats:italic>MUC2<\/jats:italic> mutation, selects an intestinal microbial community characterized by specific pro-inflammatory, genotoxic, and metabolic features that could imply a direct involvement in the pathogenesis of chronic intestinal inflammation. We report results obtained by using a variety of in vitro approaches for fecal microbiota functional characterization. These approaches include Caco-2 cell cultures and Caco-2\/THP-1 cell co-culture models for evaluation of geno-cytotoxic and pro-inflammatory properties using a panel of 43 marker RNAs assayed by RT-qPCR, and cell-based phenotypic testing for metabolic profiling of the intestinal microbial communities by Biolog EcoPlates. While adding a further step towards understanding the etiopathogenetic mechanisms underlying IBD, the results of this study provide a reliable method for phenotyping gut microbial communities, which can complement their structural characterization by providing novel functional information.\n<\/jats:p>","DOI":"10.1007\/s10753-022-01706-0","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T20:30:02Z","timestamp":1655929802000},"page":"2477-2497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phenotyping of Fecal Microbiota of Winnie, a Rodent Model of Spontaneous Chronic Colitis, Reveals Specific Metabolic, Genotoxic, and Pro-inflammatory Properties"],"prefix":"10.1007","volume":"45","author":[{"given":"Adelfia","family":"Tal\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Caterina","family":"Resta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Calcagnile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilcare","family":"Barca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Maurizio","family":"Tredici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"De Donno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Liso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Chieppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Verri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giuseppina","family":"Bozzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3768-7275","authenticated-orcid":false,"given":"Pietro","family":"Alifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"1706_CR1","doi-asserted-by":"publisher","unstructured":"Goodrich, J.K., E.R. Davenport, A.G. Clark, and R.E. Ley. 2017. The relationship between the human genome and microbiome comes into view. Annual Review of Genetics 51: 413\u2013433. https:\/\/doi.org\/10.1146\/annurev-genet-110711-155532.","DOI":"10.1146\/annurev-genet-110711-155532"},{"key":"1706_CR2","doi-asserted-by":"publisher","unstructured":"Caruso, R., B.C. Lo, and G. N\u00fa\u00f1ez. 2020. Host-microbiota interactions in inflammatory bowel disease.\u00a0Nature Reviews Immunology\u00a020 (7): 411\u2013426. https:\/\/doi.org\/10.1038\/s41577-019-0268-7.","DOI":"10.1038\/s41577-019-0268-7"},{"key":"1706_CR3","doi-asserted-by":"publisher","unstructured":"Ananthakrishnan, A.N. 2015. Epidemiology and risk factors for IBD.\u00a0Nature Reviews Gastroenterology and Hepatology\u00a012 (4): 205\u2013217. https:\/\/doi.org\/10.1038\/nrgastro.2015.34.","DOI":"10.1038\/nrgastro.2015.34"},{"key":"1706_CR4","doi-asserted-by":"publisher","unstructured":"Sankarasubramanian, J., R. Ahmad, N. Avuthu, A.B. Singh, and C. Guda. 2020. Gut microbiota and metabolic specificity in ulcerative colitis and Crohn\u2019s disease. Frontiers in Medicine (Lausanne) 7: 606298. https:\/\/doi.org\/10.3389\/fmed.2020.606298.","DOI":"10.3389\/fmed.2020.606298"},{"key":"1706_CR5","doi-asserted-by":"publisher","unstructured":"Martinson, J.N.V., N.V. Pinkham, G.W. Peters, H. Cho, J. Heng, M. Rauch, S.C. Broadaway, and S.T. Walk. 2019. Rethinking gut microbiome residency and the Enterobacteriaceae in healthy human adults. ISME Journal 3 (9): 2306\u20132318. https:\/\/doi.org\/10.1038\/s41396-019-0435-7.","DOI":"10.1038\/s41396-019-0435-7"},{"key":"1706_CR6","doi-asserted-by":"publisher","unstructured":"Zhao, S., T.D. Lieberman, M. Poyet., K.M. Kauffman, S.M. Gibbons, M. Groussin, R.J. Xavier, and E.J. Alm. 2019. Adaptive evolution within gut microbiomes of healthy people. Cell Host & Microbe 25 (5): 656\u2013667. https:\/\/doi.org\/10.1016\/j.chom.2019.03.007.","DOI":"10.1016\/j.chom.2019.03.007"},{"key":"1706_CR7","doi-asserted-by":"publisher","unstructured":"Priya, S., and R. Blekhman. 2019. Population dynamics of the human gut microbiome: Change is the only constant. Genome Biology 20 (1): 150. https:\/\/doi.org\/10.1186\/s13059-019-1775-3.","DOI":"10.1186\/s13059-019-1775-3"},{"key":"1706_CR8","doi-asserted-by":"publisher","unstructured":"Mizoguchi, A., and E. Mizoguchi. 2010. Animal models of IBD: Linkage to human disease. Current Opinion in Pharmacology 10 (5): 578\u2013587. https:\/\/doi.org\/10.1016\/j.coph.2010.05.007.","DOI":"10.1016\/j.coph.2010.05.007"},{"key":"1706_CR9","doi-asserted-by":"publisher","unstructured":"Eri, R.D., R.J. Adams, T.V. Tran, H. Tong, I. Das, D.K. Roche, I. Oancea, C.W. Png, P.L. Jeffery, G.L. Radford-Smith, et al. 2011. An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity. Mucosal Immunology 4 (3): 354\u2013364. https:\/\/doi.org\/10.1038\/mi.2010.74.","DOI":"10.1038\/mi.2010.74"},{"key":"1706_CR10","doi-asserted-by":"publisher","unstructured":"Heazlewood, C.K., M.C. Cook, R. Eri, G.R. Price, S.B. Tauro, D. Taupin, D.J. Thornton, C.W. Png, T.L. Crockford, R.J. Cornall, et al. 2008. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 5 (3): e54. https:\/\/doi.org\/10.1371\/journal.pmed.0050054.","DOI":"10.1371\/journal.pmed.0050054"},{"key":"1706_CR11","doi-asserted-by":"publisher","unstructured":"Buisine, M.P., P. Desreumaux, E. Leteurtre, M.C. Copin, J.F. Colombel, N. Porchet, and J.P. Aubert. 2001. Mucin gene expression in intestinal epithelial cells in Crohn\u2019s disease. Gut 49 (4): 544\u2013551. https:\/\/doi.org\/10.1136\/gut.49.4.544.","DOI":"10.1136\/gut.49.4.544"},{"key":"1706_CR12","doi-asserted-by":"publisher","unstructured":"Van Klinken, B.J., J.W. Van der Wal, A.W. Einerhand, H.A. B\u00fcller, and J. Dekker. 1999. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 44 (3): 387\u2013393. https:\/\/doi.org\/10.1136\/gut.44.3.387.","DOI":"10.1136\/gut.44.3.387"},{"key":"1706_CR13","doi-asserted-by":"publisher","unstructured":"Paone, P., and P.D. Cani. 2020. Mucus barrier, mucins and gut microbiota: The expected slimy partners? Gut 69 (12): 2232\u20132243. https:\/\/doi.org\/10.1136\/gutjnl-2020-322260.","DOI":"10.1136\/gutjnl-2020-322260"},{"key":"1706_CR14","doi-asserted-by":"publisher","unstructured":"Rahman, A.A., A.M. Robinson, V. Jovanovska, R. Eri, and K. Nurgali. 2015. Alterations in the distal colon innervation in Winnie mouse model of spontaneous chronic colitis. Cell and Tissue Research 362 (3): 497\u2013512. https:\/\/doi.org\/10.1007\/s00441-015-2251-3.","DOI":"10.1007\/s00441-015-2251-3"},{"key":"1706_CR15","doi-asserted-by":"publisher","unstructured":"Liso, M., S. De Santis, G. Verna, M. Dicarlo, M. Calasso, A. Santino, I. Gigante, R. Eri, S. Raveenthiraraj, A. Sobolewski, et al. 2020. A specific mutation in Muc2 determines early dysbiosis in colitis-prone Winnie mice. Inflammatory Bowel Disease 26 (4): 546\u2013556. https:\/\/doi.org\/10.1093\/ibd\/izz279.","DOI":"10.1093\/ibd\/izz279"},{"key":"1706_CR16","doi-asserted-by":"publisher","unstructured":"Klindworth, A., E. Pruesse, T. Schweer, J. Peplies, C. Quast, M. Horn, and F.O. Gl\u00f6ckner. 2013. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Research 41 (1): e1. https:\/\/doi.org\/10.1093\/nar\/gks808.","DOI":"10.1093\/nar\/gks808"},{"key":"1706_CR17","doi-asserted-by":"publisher","unstructured":"Garland, J.L. 1997. Analysis and interpretation of community-level physiological profiles in microbial ecology. FEMS Microbiology Ecology 4: 289e300. https:\/\/doi.org\/10.1111\/j.15746941.1997.tb00446.x.","DOI":"10.1111\/j.15746941.1997.tb00446.x"},{"key":"1706_CR18","doi-asserted-by":"crossref","unstructured":"Kleiveland, C.R. 2015. Co-culture Caco-2\/Immune Cells. In: Verhoeckx K, Cotter P, L\u00f3pez-Exp\u00f3sito Kleiveland C, et al. The impact of food bioactives on health: In vitro and ex vivo models. Cham (CH): Springer. Chapter 18.","DOI":"10.1007\/978-3-319-16104-4_18"},{"key":"1706_CR19","doi-asserted-by":"publisher","unstructured":"Kedia, S., and V. Ahuja. 2017. Epidemiology of inflammatory bowel disease in India: The great shift east. Inflammatory Intestinal Diseases 2 (2): 102\u2013115. https:\/\/doi.org\/10.1159\/000465522.","DOI":"10.1159\/000465522"},{"key":"1706_CR20","doi-asserted-by":"publisher","unstructured":"Jairath, V., B.G. Feagan. 2020. Global burden of inflammatory bowel disease. Lancet Gastroenterology and Hepatology 5 (1): 2\u20133. https:\/\/doi.org\/10.1016\/S2468-1253(19)30358-9.","DOI":"10.1016\/S2468-1253(19)30358-9"},{"key":"1706_CR21","doi-asserted-by":"publisher","unstructured":"Ng, S.C., H.Y. Shi, N. Hamidi, F.E. Underwood, W. Tang, E.I. Benchimol, R. Panaccione, S. Ghosh, J.C.Y. Wu, F.K.L. Chan, et al. 2018. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 390 (10114): 2769\u20132778. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0.","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"1706_CR22","doi-asserted-by":"publisher","unstructured":"Windsor, J.W., and G.G. Kaplan. 2019. Evolving epidemiology of IBD.\u00a0Current Gastroenterology Reports\u00a021 (8):40. https:\/\/doi.org\/10.1007\/s11894-019-0705-6.","DOI":"10.1007\/s11894-019-0705-6"},{"key":"1706_CR23","doi-asserted-by":"publisher","unstructured":"de Souza, H.S., and C. Fiocchi. 2016. Immunopathogenesis of IBD: Current state of the art.\u00a0Nature Reviews Gastroenterology and Hepatology\u00a013 (1): 13\u201327. https:\/\/doi.org\/10.1038\/nrgastro.2015.186.","DOI":"10.1038\/nrgastro.2015.186"},{"key":"1706_CR24","doi-asserted-by":"publisher","unstructured":"Jostins, L., S. Ripke, R.K. Weersma, R.H. Duerr, D.P. McGovern, K.Y. Hui, J.C. Lee, L.P. Schumm, Y. Sharma, C.A. Anderson, et al.\u00a02012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (7422): 119\u2013124. https:\/\/doi.org\/10.1038\/nature11582.","DOI":"10.1038\/nature11582"},{"key":"1706_CR25","doi-asserted-by":"publisher","unstructured":"Annese, V. 2020. Genetics and epigenetics of IBD. Pharmacology Research 159: 104892. https:\/\/doi.org\/10.1016\/j.phrs.2020.104892.","DOI":"10.1016\/j.phrs.2020.104892"},{"key":"1706_CR26","doi-asserted-by":"publisher","unstructured":"Lee, M., and E.B. Chang. 2020. Inflammatory bowel diseases (IBD) (inflammatory bowel diseases and the microbiome: Searching the crime scene for clues). Gastroenterology S0016\u20135085(20)35507\u20134. https:\/\/doi.org\/10.1053\/j.gastro.2020.09.056.","DOI":"10.1053\/j.gastro.2020.09.056"},{"key":"1706_CR27","doi-asserted-by":"publisher","unstructured":"Iida, N., A. Dzutsev, C.A. Stewart, L. Smith, N. Bouladoux, R.A. Weingarten, D.A. Molina, R. Salcedo, T. Back, S. Cramer, et al. 2013. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342 (6161): 967\u2013970. https:\/\/doi.org\/10.1126\/science.1240527.","DOI":"10.1126\/science.1240527"},{"key":"1706_CR28","doi-asserted-by":"publisher","unstructured":"Parker, B.J., P.A. Wearsch, A.C.M. Veloo, and A. Rodriguez-Palacios. 2020. The genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health. Frontiers in Immunology 11: 906. https:\/\/doi.org\/10.3389\/fimmu.2020.00906.","DOI":"10.3389\/fimmu.2020.00906"},{"key":"1706_CR29","doi-asserted-by":"publisher","unstructured":"Louis, P., and H.J. Flint. 2009. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters 294 (1): 1\u20138. https:\/\/doi.org\/10.1111\/j.1574-6968.2009.01514.x.","DOI":"10.1111\/j.1574-6968.2009.01514.x"},{"key":"1706_CR30","doi-asserted-by":"publisher","unstructured":"Vacca, M., G. Celano, F.M. Calabrese, P. Portincasa, M. Gobbetti, and M. De Angelis. 2020. The controversial role of human gut lachnospiraceae. Microorganisms 8 (4): 573. https:\/\/doi.org\/10.3390\/microorganisms8040573.","DOI":"10.3390\/microorganisms8040573"},{"key":"1706_CR31","doi-asserted-by":"publisher","unstructured":"Lagkouvardos, I., R. Pukall, B. Abt, B.U. Foesel, J.P. Meier-Kolthoff, N. Kumar, A. Bresciani, I. Mart\u00ednez, S. Just, C. Ziegler, et al. 2016. The mouse intestinal bacterial collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota. Nature Microbiology 1 (10): 16131. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.131.","DOI":"10.1038\/nmicrobiol.2016.131"},{"key":"1706_CR32","doi-asserted-by":"publisher","unstructured":"Kenny, D.J., D.R. Plichta, D. Shungin, N. Koppel, A.B. Hall, B. Fu, R.S. Vasan, S.Y. Shaw, H. Vlamakis, E.P. Balskus, et al. 2020. Cholesterol metabolism by uncultured human gut bacteria influences host cholesterol level. Cell Host & Microbe 28 (2): 245\u2013257.e6. https:\/\/doi.org\/10.1016\/j.chom.2020.05.013.","DOI":"10.1016\/j.chom.2020.05.013"},{"key":"1706_CR33","doi-asserted-by":"publisher","unstructured":"Koh, A., F. De Vadder, P. Kovatcheva-Datchary, F. B\u00e4ckhed, et al. 2016. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165 (6): 1332\u20131345. https:\/\/doi.org\/10.1016\/j.cell.2016.05.041.","DOI":"10.1016\/j.cell.2016.05.041"},{"key":"1706_CR34","doi-asserted-by":"publisher","unstructured":"Morrison, D.J., and T. Preston. 2016. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7 (3): 189\u2013200. https:\/\/doi.org\/10.1080\/19490976.2015.1134082.","DOI":"10.1080\/19490976.2015.1134082"},{"key":"1706_CR35","doi-asserted-by":"publisher","unstructured":"Sun, X., Y. Cui, Y. Su, Z. Gao, X. Diao, J. Li, X. Zhu, D. Li, Z. Li, C. Wang, et al. 2021. Dietary fiber ameliorates lipopolysaccharide-induced intestinal barrier function damage in piglets by modulation of intestinal microbiome. mSystems 6 (2): e01374\u201320. https:\/\/doi.org\/10.1128\/mSystems.01374-20.","DOI":"10.1128\/mSystems.01374-20"},{"key":"1706_CR36","doi-asserted-by":"publisher","unstructured":"Clemente, J.C., L.K. Ursell, L.W. Parfrey, and R. Knight. 2012. The impact of the gut microbiota on human health: An integrative view. Cell 148 (6): 1258\u20131270. https:\/\/doi.org\/10.1016\/j.cell.2012.01.035.","DOI":"10.1016\/j.cell.2012.01.035"},{"key":"1706_CR37","doi-asserted-by":"publisher","unstructured":"Wang, R., M. Moniruzzaman, K.Y. Wong, P. Wiid, A. Harding, R. Giri, W.H. Tong, J. Creagh, J. Begun, M.A. McGuckin, et al. 2021. Gut microbiota shape the inflammatory response in mice with an epithelial defect. Gut Microbes 13 (1): 1\u201318. https:\/\/doi.org\/10.1080\/19490976.2021.1887720.","DOI":"10.1080\/19490976.2021.1887720"},{"key":"1706_CR38","doi-asserted-by":"publisher","unstructured":"Dicarlo, M., G. Teti, G. Verna, M. Liso, E. Cavalcanti, A. Sila, S. Raveenthiraraj, M. Mastronardi, A. Santino, G. Serino, et al. 2019. Quercetin exposure suppresses the inflammatory pathway in intestinal organoids from Winnie mice.\u00a0International Journal of Molecular Sciences\u00a020 (22): 5771. https:\/\/doi.org\/10.3390\/ijms20225771.","DOI":"10.3390\/ijms20225771"},{"issue":"3","key":"1706_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nm0305-254","volume":"11","author":"M Rescigno","year":"2005","unstructured":"Rescigno, M., and M. Chieppa. 2005. Gut-level decisions in peace and war. Nature Medicine 11 (3): 254\u2013255. https:\/\/doi.org\/10.1038\/nm0305-254.","journal-title":"Nature Medicine"},{"issue":"20","key":"1706_CR40","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1007\/s00018-019-03190-6","volume":"76","author":"G Wang","year":"2019","unstructured":"Wang, G., S. Huang, Y. Wang, S. Cai, H. Yu, H. Liu, X. Zeng, G. Zhang, and S. Qiao. 2019. Bridging intestinal immunity and gut microbiota by metabolites. Cellular and Molecular Life Sciences 76 (20): 3917\u20133937. https:\/\/doi.org\/10.1007\/s00018-019-03190-6.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"9","key":"1706_CR41","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/ibd.21282","volume":"16","author":"E Cario","year":"2010","unstructured":"Cario, E. 2010. Toll-like receptors in inflammatory bowel diseases: A decade later. Inflammatory Bowel Diseases 16 (9): 1583\u20131597. https:\/\/doi.org\/10.1002\/ibd.21282.","journal-title":"Inflammatory Bowel Diseases"},{"key":"1706_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fimmu.2018.00072","volume":"9","author":"Y Lu","year":"2018","unstructured":"Lu, Y., X. Li, S. Liu, Y. Zhang, and D. Zhang. 2018. Toll-like receptors and inflammatory bowel disease. Frontiers in Immunology 9: 72. https:\/\/doi.org\/10.3389\/fimmu.2018.00072.","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"1706_CR43","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.4049\/jimmunol.176.7.4258","volume":"176","author":"E Cario","year":"2006","unstructured":"Cario, E., D.T. Golenbock, A. Visintin, M. R\u00fcnzi, G. Gerken, and D.K. Podolsky. 2006. Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance. The Journal of Immunology 176 (7): 4258\u20134266. https:\/\/doi.org\/10.4049\/jimmunol.176.7.4258.","journal-title":"The Journal of Immunology"},{"issue":"6","key":"1706_CR44","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1172\/JCI34610","volume":"118","author":"N Kamada","year":"2008","unstructured":"Kamada, N., T. Hisamatsu, S. Okamoto, H. Chinen, T. Kobayashi, T. Sato, A. Sakuraba, M.T. Kitazume, A. Sugita, K. Koganei, et al. 2008. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23\/IFN-gamma axis. The Journal of Clinical Investigation 118 (6): 2269\u20132280. https:\/\/doi.org\/10.1172\/JCI34610.","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"1706_CR45","doi-asserted-by":"publisher","first-page":"G472","DOI":"10.1152\/ajpgi.1998.274.3.G472","volume":"274","author":"MA Meijssen","year":"1998","unstructured":"Meijssen, M.A., S.L. Brandwein, H.C. Reinecker, A.K. Bhan, and D.K. Podolsky. 1998. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. American Journal of Physiology 274 (3): G472-479. https:\/\/doi.org\/10.1152\/ajpgi.1998.274.3.G472.","journal-title":"American Journal of Physiology"},{"issue":"3","key":"1706_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00595-005-3144-y","volume":"36","author":"Y Toiyama","year":"2006","unstructured":"Toiyama, Y., T. Araki, S. Yoshiyama, J. Hiro, C. Miki, and M. Kusunoki. 2006. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surgery Today 36 (3): 287\u2013290. https:\/\/doi.org\/10.1007\/s00595-005-3144-y.","journal-title":"Surgery Today"},{"issue":"23","key":"1706_CR47","doi-asserted-by":"publisher","first-page":"20431","DOI":"10.1074\/jbc.M110333200","volume":"277","author":"MT Abreu","year":"2002","unstructured":"Abreu, M.T., E.T. Arnold, L.S. Thomas, R. Gonsky, Y. Zhou, B. Hu, and M. Arditi. 2002. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. Journal of Biological Chemistry 277 (23): 20431\u201320437. https:\/\/doi.org\/10.1074\/jbc.M110333200.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"1706_CR48","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1128\/IAI.71.6.3503-3511.2003","volume":"71","author":"M Suzuki","year":"2003","unstructured":"Suzuki, M., T. Hisamatsu, and D.K. Podolsky. 2003. Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infection and Immunity 71 (6): 3503\u20133511. https:\/\/doi.org\/10.1128\/IAI.71.6.3503-3511.2003.","journal-title":"Infection and Immunity"},{"issue":"5\u20136","key":"1706_CR49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2119\/2007-00135.Ferwerda","volume":"14","author":"B Ferwerda","year":"2008","unstructured":"Ferwerda, B., M.B. McCall, K. Verheijen, B.J. Kullberg, A.J. van der Ven, J.W. Van der Meer, and M.G. Netea. 2008. Functional consequences of toll-like receptor 4 polymorphisms. Molecular Medicine 14 (5\u20136): 346\u2013352. https:\/\/doi.org\/10.2119\/2007-00135.Ferwerda.","journal-title":"Molecular Medicine"},{"issue":"12","key":"1706_CR50","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1128\/IAI.68.12.7010-7017.2000","volume":"68","author":"E Cario","year":"2000","unstructured":"Cario, E., and D.K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infection and Immunity 68 (12): 7010\u20137017. https:\/\/doi.org\/10.1128\/IAI.68.12.7010-7017.2000.","journal-title":"Infection and Immunity"},{"issue":"4","key":"1706_CR51","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.immuni.2016.03.009","volume":"44","author":"JY Yang","year":"2016","unstructured":"Yang, J.Y., M.S. Kim, E. Kim, J.H. Cheon, Y.S. Lee, Y. Kim, S.H. Lee, S.U. Seo, S.H. Shin, S.S. Choi, et al. 2016. Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-\u03b2 production. Immunity 44 (4): 889\u2013900. https:\/\/doi.org\/10.1016\/j.immuni.2016.03.009.","journal-title":"Immunity"},{"issue":"2","key":"1706_CR52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/cancers13020283","volume":"13","author":"S De Santis","year":"2021","unstructured":"De Santis, S., M. Liso, M. Vacca, G. Verna, E. Cavalcanti, S. Coletta, F.M. Calabrese, R. Eri, A. Lippolis, R. Armentano, et al. 2021. Dysbiosis triggers ACF development in genetically predisposed subjects. Cancers (Basel) 13 (2): 283. https:\/\/doi.org\/10.3390\/cancers13020283.","journal-title":"Cancers (Basel)"},{"key":"1706_CR53","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3389\/fphys.2018.01534","volume":"9","author":"EA Kennedy","year":"2018","unstructured":"Kennedy, E.A., K.Y. King, and M.T. Baldridge. 2018. Mouse microbiota models: Comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Frontiers in Physiology 9: 1534. https:\/\/doi.org\/10.3389\/fphys.2018.01534.","journal-title":"Frontiers in Physiology"},{"key":"1706_CR54","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.3389\/fmicb.2018.03289","volume":"9","author":"T Le Roy","year":"2019","unstructured":"Le Roy, T., J. Deb\u00e9dat, F. Marquet, C. Da-Cunha, F. Ichou, M. Guerre-Millo, N. Kapel, J. Aron-Wisnewsky, and K. Cl\u00e9ment. 2019. Comparative evaluation of microbiota engraftment following fecal microbiota transfer in mice models: Age, kinetic and microbial status matter. Frontiers in Microbiology 9: 3289. https:\/\/doi.org\/10.3389\/fmicb.2018.03289.","journal-title":"Frontiers in Microbiology"},{"key":"1706_CR55","doi-asserted-by":"publisher","unstructured":"Bankole, E., E. Read, M.A. Curtis, J.F. Neves, and J.A. Garnett. 2021. The relationship between mucins and ulcerative colitis: A systematic review.\u00a0Journal of Clinical Medicine\u00a010 (9):\u00a01935. https:\/\/doi.org\/10.3390\/jcm10091935.","DOI":"10.3390\/jcm10091935"},{"key":"1706_CR56","doi-asserted-by":"publisher","unstructured":"Jacobs, J.P., L. Lin, M. Goudarzi, P. Ruegger, D.P. McGovern, A.J. Jr Fornace, J. Borneman, L. Xia, and J. Braun. 2017. Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency. Gut Microbes 8 (1): 1\u201316. https:\/\/doi.org\/10.1080\/19490976.2016.1257469.","DOI":"10.1080\/19490976.2016.1257469"},{"key":"1706_CR57","doi-asserted-by":"publisher","unstructured":"Vancamelbeke, M., T. Vanuytsel, R. Farr\u00e9, S. Verstockt, M. Ferrante, G. Van Assche, P. Rutgeerts, F. Schuit, S. Vermeire, I. Arijs, et al. 2017. Genetic and transcriptomic bases of intestinal epithelial barrier dysfunction in inflammatory bowel disease.\u00a0Inflammatory Bowel Diseases\u00a023 (10): 1718\u20131729. https:\/\/doi.org\/10.1097\/MIB.0000000000001246.","DOI":"10.1097\/MIB.0000000000001246"},{"key":"1706_CR58","doi-asserted-by":"publisher","unstructured":"Visschedijk, M.C., R. Alberts, S. Mucha, P. Deelen, D.J. de Jong, M. Pierik, L.M. Spekhorst, F. Imhann, A.E. van der Meulen-de Jong, C.J. van der Woude, et al. 2016. Pooled resequencing of 122 ulcerative colitis genes in a large Dutch cohort suggests population-specific associations of rare variants in MUC2. PLoS One 11 (8): e0159609. https:\/\/doi.org\/10.1371\/journal.pone.0159609.","DOI":"10.1371\/journal.pone.0159609"},{"key":"1706_CR59","doi-asserted-by":"publisher","unstructured":"Qu, D., G. Wang, L. Yu, F. Tian, W. Chen, and Q. Zhai. 2021. The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation.\u00a0Carbohydrate Polymers\u00a0258: 117651. https:\/\/doi.org\/10.1016\/j.carbpol.2021.117651.","DOI":"10.1016\/j.carbpol.2021.117651"},{"key":"1706_CR60","doi-asserted-by":"publisher","unstructured":"Wellington, M.O., K. Hamonic, J.E.C. Krone, J.K. Htoo, A.G. Van Kessel, and D.A. Columbus. 2020. Effect of dietary fiber and threonine content on intestinal barrier function in pigs challenged with either systemic E. coli lipopolysaccharide or enteric Salmonella Typhimurium.\u00a0Journal of Animal Science and Biotechnology\u00a011: 38. https:\/\/doi.org\/10.1186\/s40104-020-00444-3.","DOI":"10.1186\/s40104-020-00444-3"},{"issue":"1","key":"1706_CR61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13059-019-1775-3","volume":"20","author":"S Priya","year":"2019","unstructured":"Priya, S., and R. Blekhman. 2019. Population dynamics of the human gut microbiome: Change is the only constant. Genome Biology 20 (1): 150. https:\/\/doi.org\/10.1186\/s13059-019-1775-3.","journal-title":"Genome Biology"},{"issue":"1","key":"1706_CR62","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1038\/s41467-020-19940-1","volume":"11","author":"L Tian","year":"2020","unstructured":"Tian, L., X.W. Wang, A.K. Wu, Y. Fan, J. Friedman, A. Dahlin, M.K. Waldor, G.M. Weinstock, S.T. Weiss, and Y.Y. Liu. 2020. Deciphering functional redundancy in the human microbiome. Nature Communications 11 (1): 6217. https:\/\/doi.org\/10.1038\/s41467-020-19940-1.","journal-title":"Nature Communications"},{"issue":"1","key":"1706_CR63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13073-020-00765-y","volume":"12","author":"Y Yan","year":"2020","unstructured":"Yan, Y., L.H. Nguyen, E.A. Franzosa, and C. Huttenhower. 2020. Strain-level epidemiology of microbial communities and the human microbiome. Genome Med 12 (1): 71. https:\/\/doi.org\/10.1186\/s13073-020-00765-y.","journal-title":"Genome Med"},{"key":"1706_CR64","doi-asserted-by":"publisher","unstructured":"Dubinsky, V., I. Dotan, and U. Gophna. 2020. Carriage of colibactin-producing bacteria and colorectal cancer risk. Trends in Microbiology 28 (11): 874\u2013876. https:\/\/doi.org\/10.1016\/j.tim.2020.05.015.","DOI":"10.1016\/j.tim.2020.05.015"},{"key":"1706_CR65","doi-asserted-by":"publisher","unstructured":"Samba-Louaka, A., J.P. Nougayr\u00e8de, C. Watrin, E. Oswald, and F. Taieb. 2009. The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells.\u00a0Infection and Immunity\u00a077 (12): 5471\u20135477. https:\/\/doi.org\/10.1128\/IAI.00860-09.","DOI":"10.1128\/IAI.00860-09"},{"key":"1706_CR66","doi-asserted-by":"publisher","unstructured":"Taieb, F., J.P. Nougayr\u00e8de, and E. Oswald. 2011. Cycle inhibiting factors (cifs): cyclomodulins that usurp the ubiquitin-dependent degradation pathway of host cells. Toxins (Basel) 3 (4): 356\u2013368. https:\/\/doi.org\/10.3390\/toxins3040356.","DOI":"10.3390\/toxins3040356"},{"key":"1706_CR67","doi-asserted-by":"publisher","unstructured":"Liebl, M.C., and T.G. Hofmann. 2021. The role of p53 signaling in colorectal cancer. Cancers (Basel) 13 (9): 2125. https:\/\/doi.org\/10.3390\/cancers13092125.","DOI":"10.3390\/cancers13092125"},{"key":"1706_CR68","doi-asserted-by":"publisher","unstructured":"Alhinai, E.A., G.E. Walton, and D.M. Commane. 2019. The role of the gut microbiota in colorectal cancer causation.\u00a0International Journal of Molecular Sciences\u00a020 (21): 5295. https:\/\/doi.org\/10.3390\/ijms20215295.","DOI":"10.3390\/ijms20215295"},{"key":"1706_CR69","doi-asserted-by":"publisher","unstructured":"Wu, S., K.J. Rhee, E. Albesiano, S. Rabizadeh, X. Wu, H.R. Yen, D.L. Huso, F.L. Brancati, E. Wick, F. McAllister, et al. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Medicine 15 (9): 1016\u20131022. https:\/\/doi.org\/10.1038\/nm.2015.","DOI":"10.1038\/nm.2015"},{"issue":"Pt 11","key":"1706_CR70","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1242\/jcs.03455","volume":"120","author":"S Wu","year":"2007","unstructured":"Wu, S., K.J. Rhee, M. Zhang, A. Franco, and C.L. Sears. 2007. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. Journal of Cell Science 120 (Pt 11): 1944\u20131952. https:\/\/doi.org\/10.1242\/jcs.03455.","journal-title":"Journal of Cell Science"},{"key":"1706_CR71","doi-asserted-by":"publisher","unstructured":"Van Lanen, S.G., and B. Shen. 2008. Biosynthesis of enediyne antitumor antibiotics.\u00a0Current Topics in Medicinal Chemistry\u00a08 (6): 448\u2013459. https:\/\/doi.org\/10.2174\/156802608783955656.","DOI":"10.2174\/156802608783955656"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01706-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-022-01706-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01706-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T07:15:59Z","timestamp":1667978159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-022-01706-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1007\/s10753-022-01706-0","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}